Namibia - Kiingereza - Namibia Medicines Regulatory Council

amersham health south africa - gadodiamide - injection - gadodiamide injection 287mg/ml 5ml

Namibia - Kiingereza - Namibia Medicines Regulatory Council

amersham health south africa - gadodiamide - injection - gadodiamide injection 287mg/ml 10ml

Namibia - Kiingereza - Namibia Medicines Regulatory Council

amersham health south africa - gadodiamide - injection - gadodiamide injection 287mg/ml 15ml

Namibia - Kiingereza - Namibia Medicines Regulatory Council

amersham health south africa - gadodiamide - injection - gadodiamide injection 287mg/ml 20ml

Namibia - Kiingereza - Namibia Medicines Regulatory Council

amersham health south africa - iodixanol (anhydrous) - injection - iodixanol (anhydrous) 652mg = 320mg iodine/ml, 20ml

Namibia - Kiingereza - Namibia Medicines Regulatory Council

amersham health south africa - iodixanol (anhydrous) - injection - iodixanol (anhydrous) 652mg = 320mg iodine/ml, 50ml

Namibia - Kiingereza - Namibia Medicines Regulatory Council

amersham health south africa - iodixanol (anhydrous) - injection - iodixanol (anhydrous) 652mg = 320mg iodine/ml, 100ml

Namibia - Kiingereza - Namibia Medicines Regulatory Council

amersham health south africa - iodixanol (anhydrous) - injection - iodixanol (anhydrous) 652mg = 320mg iodine/ml, 200ml

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - indium (111in) hydroxyquinoline, quantity: 0.01 microgram/ml (equivalent: indium (111in) chloride, qty 37 mbq/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; hepes; oxyquinoline; polysorbate 80 - for in vitro radiolabelling of separated leucocytes and platelets which are subsequently reinjected intravenously for investigative purposes using appropriate imaging/counting procedures.